These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 2686247
1. [Histomorphologic findings of the bone marrow in chronic myeloproliferative diseases]. Thiele J, Fischer R. Z Hautkr; 1989 Oct 15; 64(10):903-4, 909-12. PubMed ID: 2686247 [Abstract] [Full Text] [Related]
2. [Jamshidi biopsy in clinical hematology. Method, indications and results of over 1,000 completed biopsies with special reference to chronic myeloproliferative diseases]. Seewann HL. Wien Med Wochenschr Suppl; 1986 Oct 15; 100():1-24. PubMed ID: 3471009 [Abstract] [Full Text] [Related]
3. Megakaryopoiesis in chronic myeloproliferative diseases. A morphometric evaluation with special emphasis on primary thrombocythemia. Thiele J, Funke S, Holgado S, Choritz H, Georgii A. Anal Quant Cytol; 1984 Sep 15; 6(3):155-67. PubMed ID: 6594964 [Abstract] [Full Text] [Related]
4. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders]. Bettini R, Marzetta K, Miglioranza A, Redaelli S, Maino C, Maffiolini A, Gorini M. Recenti Prog Med; 2003 Sep 15; 94(7-8):314-20. PubMed ID: 12868237 [Abstract] [Full Text] [Related]
5. Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl. Thiele J, Kvasnicka HM, Vardiman J. Best Pract Res Clin Haematol; 2006 Sep 15; 19(3):413-37. PubMed ID: 16781481 [Abstract] [Full Text] [Related]
6. Chronic myeloproliferative diseases with an elevated platelet count (in excess of 1,000,000/microliter): a clinicopathological study on 46 patients with special emphasis on primary (essential) thrombocythemia. Thiele J, Moedder B, Kremer B, Zankovich R, Fischer R. Hematol Pathol; 1987 Sep 15; 1(4):227-37. PubMed ID: 3504437 [Abstract] [Full Text] [Related]
7. Modern diagnostics in chronic myeloproliferative diseases (CMPDs). Haferlach T, Kern W, Schnittger S, Schoch C. Ann Hematol; 2004 Sep 15; 83 Suppl 1():S59-61. PubMed ID: 15124674 [Abstract] [Full Text] [Related]
8. Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading. Thiele J, Kvasnicka HM. Pathobiology; 2007 Sep 15; 74(2):89-96. PubMed ID: 17587880 [Abstract] [Full Text] [Related]
9. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia. Tefferi A. Semin Hematol; 1999 Jan 15; 36(1 Suppl 2):3-8. PubMed ID: 9930550 [Abstract] [Full Text] [Related]
10. [Diagnosis of chronic myeloproliferative diseases based on bone marrow biopsy]. Matolcsy A, Kónya T, Wéber E. Orv Hetil; 1992 Jun 28; 133(26):1617-20, 1625-6. PubMed ID: 1614699 [Abstract] [Full Text] [Related]
11. Chronic myeloproliferative diseases on a pathologist's desk--a dilemma of distinct entities versus a clinico-pathologic continuum. A descriptive study based on a material from the Polish population. Rudzki Z, Papla B, Stachura J. Pol J Pathol; 2004 Jun 28; 55(1):13-23. PubMed ID: 15195702 [Abstract] [Full Text] [Related]
12. Classification of Ph-negative chronic myeloproliferative disorders--morphology as the yardstick of classification. Kvasnicka HM, Thiele J. Pathobiology; 2007 Jun 28; 74(2):63-71. PubMed ID: 17587877 [Abstract] [Full Text] [Related]
13. [Molecular diagnosis of chronic myeloproliferative diseases and myelodysplastic syndromes]. Bock O. Verh Dtsch Ges Pathol; 2007 Jun 28; 91():140-53. PubMed ID: 18314608 [Abstract] [Full Text] [Related]
14. Osteoclasts and bone remodeling in chronic myeloproliferative disorders. A histochemical and morphometric study on trephine biopsies in 165 patients. Thiele J, Hoeppner B, Wienhold S, Schneider G, Fischer R, Zankovich R. Pathol Res Pract; 1989 Jun 28; 184(6):591-9. PubMed ID: 2780431 [Abstract] [Full Text] [Related]
15. Bone marrow histopathology in myeloproliferative disorders--current diagnostic approach. Thiele J, Kvasnicka HM, Orazi A. Semin Hematol; 2005 Oct 28; 42(4):184-95. PubMed ID: 16210032 [Abstract] [Full Text] [Related]
16. [Histopathology and molecular pathology of chronic myeloproliferative disorders]. Kreipe HH. Veroff Pathol; 1993 Oct 28; 141():1-158. PubMed ID: 8372486 [Abstract] [Full Text] [Related]
17. [So-called primary (idiopathic) osteomyelofibrosis/-sclerosis (OMF) within the scope of chronic myeloproliferative diseases. I. Initial clinical and histologic findings in 102 patients with special reference to early hyperplastic and advanced fibrosclerotic stages]. Zankovich R, Thiele J, Mödder B, Steinberg T, Simon KG, Fischer R, Diehl V. Med Klin (Munich); 1988 Oct 04; 83(19):617-28. PubMed ID: 3185420 [No Abstract] [Full Text] [Related]
18. Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification. Buhr T, Georgii A, Choritz H. Pathol Res Pract; 1993 Mar 04; 189(2):121-32. PubMed ID: 8321741 [Abstract] [Full Text] [Related]
19. Hematopathologic findings in the myeloproliferative disorders. Dickstein JI, Vardiman JW. Semin Oncol; 1995 Aug 04; 22(4):355-73. PubMed ID: 7638633 [Abstract] [Full Text] [Related]
20. Chronic myeloproliferative disorders in bone marrow biopsies. Georgii A, Vykoupil KF, Buhr T, Choritz H, Döhler U, Kaloutsi V, Werner M. Pathol Res Pract; 1990 Feb 04; 186(1):3-27. PubMed ID: 2179909 [Abstract] [Full Text] [Related] Page: [Next] [New Search]